Trade AstraZeneca PLC - USD - AZN CFD
Add to favourite- Summary
- Historical Data
Spread | 0.11 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 70.76 |
Open | 71.33 |
1-Year Change | -5.56% |
Day's Range | 70.67 - 71.33 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 23, 2024 | 70.76 | 0.40 | 0.57% | 70.36 | 71.04 | 70.10 |
Apr 22, 2024 | 70.06 | 0.46 | 0.66% | 69.60 | 70.43 | 69.31 |
Apr 19, 2024 | 68.50 | 0.43 | 0.63% | 68.07 | 68.65 | 68.07 |
Apr 18, 2024 | 68.31 | 0.14 | 0.21% | 68.17 | 68.73 | 68.10 |
Apr 17, 2024 | 68.47 | -0.19 | -0.28% | 68.66 | 68.74 | 68.13 |
Apr 16, 2024 | 68.21 | 0.00 | 0.00% | 68.21 | 68.54 | 67.95 |
Apr 15, 2024 | 68.69 | -0.34 | -0.49% | 69.03 | 69.50 | 68.48 |
Apr 12, 2024 | 68.88 | -0.64 | -0.92% | 69.52 | 69.77 | 68.54 |
Apr 11, 2024 | 69.39 | -0.48 | -0.69% | 69.87 | 70.01 | 68.83 |
Apr 10, 2024 | 68.04 | 0.49 | 0.73% | 67.55 | 68.11 | 67.36 |
Apr 9, 2024 | 68.34 | 0.19 | 0.28% | 68.15 | 68.40 | 67.90 |
Apr 8, 2024 | 67.64 | 0.18 | 0.27% | 67.46 | 67.71 | 67.17 |
Apr 5, 2024 | 67.38 | 0.48 | 0.72% | 66.90 | 67.66 | 66.81 |
Apr 4, 2024 | 67.27 | -1.56 | -2.27% | 68.83 | 68.89 | 67.24 |
Apr 3, 2024 | 66.75 | 0.33 | 0.50% | 66.42 | 67.29 | 66.36 |
Apr 2, 2024 | 66.94 | -0.10 | -0.15% | 67.04 | 67.32 | 66.69 |
Apr 1, 2024 | 67.18 | -0.96 | -1.41% | 68.14 | 68.14 | 66.99 |
Mar 28, 2024 | 67.66 | -0.48 | -0.70% | 68.14 | 68.30 | 67.62 |
Mar 27, 2024 | 68.19 | 1.11 | 1.65% | 67.08 | 68.32 | 67.00 |
Mar 26, 2024 | 66.29 | 0.10 | 0.15% | 66.19 | 66.40 | 65.71 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
AstraZeneca - USD Company profile
About AstraZeneca plc (ADR)
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc (ADR) revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.
Equity composition
Ordinary Shares $.25, 12/10, 2.4B auth. 1,409,023,452 issd.Insiders own 0.37%. 5/93, Company formed through spin-off of a wholly-owned subsidiary ICI Zeneca Limited. Basis: 1-for-1. *FY'01 Q's are restated for deferred tax. 07/15, 2-for-1, Stock Split.
Industry: | Pharmaceuticals (NEC) |
1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com